Amivantamab Plus Lazertinib in Atypical EGFR-mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results from CHRYSALIS-2.
Byoung Chul Cho,Yongsheng Wang,Enriqueta Felip,Jiuwei Cui,Alexander I. Spira,Joel W. Neal,Christina Baik,Melina Elpi Marmarelis,Eiki Ichihara,Jong-Seok Lee,Se-Hoon Lee,James Chih-Hsin Yang,Sebastian Yves Friedrich Michels,Zacharias Anastasiou,Joshua C. Curtin,Xuesong Lyu, Isabelle Leconte,Leonardo Trani,Mahadi Baig,Pascale Tomasini JOURNAL OF CLINICAL ONCOLOGY（2024）
AI 理解论文
溯源树
样例
